Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Trails Edge Capital Partners, LP
Form 13F · Q2 2026

Trails Edge Capital Partners, LP

CIK 2077247申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$6.3亿
申報組合市值
35
持倉數量
3
Quarters on record
Top 50
持倉數量

Trails Edge Capital Partners, LP——持倉

共 35 個持倉中的前 35 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1LBRX Lb Pharmaceuticals Inc1.5M+15.4%$4943万7.8%
2NRIX Nurix Therapeutics Inc1.6M−9.8%$3817万6.1%
3IMCR Immunocore Hldgs Plc1.1M+55.8%$3376万5.4%
4TRAX First Tracks Biotherapeutics1.5M—$3046万4.8%
5FDMT 4D Molecular Therapeutics In2.2M+71.0%$2963万4.7%
6BMRN Biomarin Pharmaceutical Inc512,000—$2930万4.7%
7DSGN Design Therapeutics Inc2.0M+134.9%$2896万4.6%
8XENE Xenon Pharmaceuticals Inc440,000+0.0%$2656万4.2%
9MIRM Mirum Pharmaceuticals Inc223,312−33.0%$2614万4.2%
10INSM Insmed Inc230,331—$2456万3.9%
11CYTK Cytokinetics Inc288,089−4.0%$2454万3.9%
12SNDX Syndax Pharmaceuticals Inc1.1M+58.2%$2426万3.9%
13NGNE Neurogene Inc714,885−8.7%$2248万3.6%
14KLRA Kailera Therapeutics Inc984,786—$2169万3.4%
15RVMD Revolution Medicines Inc115,750−52.8%$2168万3.4%
16IKT Inhibikase Therapeutics Inc9.1M+12.3%$1837万2.9%
17INCY Incyte Corp155,000—$1757万2.8%
18AVTX Avalo Therapeutics Inc891,881—$1648万2.6%
19MLTX Moonlake Immunotherapeutics750,000—$1460万2.3%
20FTH Faeth Therapeutics Inc515,335+312.3%$1288万2.0%
21XFOR X4 Pharmaceuticals Inc2.6M+0.0%$1201万1.9%
22IRD Opus Genetics Inc2.7M+448.7%$1128万1.8%
23SLGL Sol-Gel Technologies Ltd139,445+63.1%$1034万1.6%
24AURA Aura Biosciences Inc1.4M—$1025万1.6%
25IPSC Century Therapeutics Inc4.1M+68.8%$1013万1.6%
26IVA Inventiva Sa2.7M+0.0%$1005万1.6%
27CAMP Camp4 Therapeutics Corp1.9M−0.3%$845万1.3%
28ALT Altimmune Inc2.7M—$809万1.3%
29NERV Minerva Neurosciences Inc1.4M+0.0%$788万1.3%
30PMN Promis Neurosciences Inc557,103+0.0%$733万1.2%
31OKUR Onkure Therapeutics Inc1.4M—$656万1.0%
32FORTE BIOSCIENCES INC Forte Biosciences Inc273,181—$581万0.9%
33RACC Research Alliance Corp Iii500,000—$535万0.8%
34VTVT Vtv Therapeutics Inc85,192−39.0%$321万0.5%
35IMA Imagenebio Inc282,004—$166万0.3%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。